Texas Department of State Health Services
Funding Information Center
Toll free: 1-888-963-7111 ext. 7684
Austin phone: (512) 776-7684
Fax: (512) 776-7683
The Texas Department of State Health Services Funding Alert is published weekly. If you wish to subscribe to the Funding Information Center Funding Alert and other services, please call (512) 776-7684 or fill out our online subscription form which can be found at: https://webds.dshs.state.tx.us/fic/subscribe.htm. Information in the Funding Alert is not copyrighted and may be reproduced. The Texas Department of State Health Services Funding Information Center would appreciate credit for the material used and a copy of the reprint. For information on viewing Adobe Acrobat .pdf and other files, see file viewing information.
Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.
Funding News and Grant Tips
FIC Releases Holiday Funding Alert Schedule
The Funding Information Center will distribute the December 25 Funding Alert today, Friday, December 21 and we will not publish a Funding Alert on Tuesday, January 1 due to the holidays.
We will return to our normal distribution schedule the following week with the January 8, 2013 issue.
Happy Holidays from the Funding Information Center staff!
From the Funding Information Center, 12/7/12
Foundation Discontinues Texas Directory of Foundations in Print; On-Line Version will End in One Year
The San Antonio Area Foundation has announced that they will not publish a 2012 edition of the hard-cover Texas Directory of Foundations. They have also announced that sales of one-year subscriptions to the on-line version will be discontinued after Dec. 31.
The decision was made to no longer publish the directory "in order to maximize our resources and ensure we are not duplicating efforts within our community."
Copies of the 2011 Directory of Texas Foundations (30th edition) are still available. Those interested should e-mail Pershama Dailey at pdailey@saafdn.org for more information.
This spring the San Antonio Area Foundation will be moving into new office space at 303 East Pearl Parkway, San Antonio, Texas 78215 and also hopes to increase the resources available for nonprofit use in their library.
San Antonio Area Foundation e-mail, 12/17/12
Public Funding Opportunities
Actuarial Services for the Texas Medicaid Wellness Program: RFP# 529-13-0004
SOURCE: Texas Health and Human Services Commission (HHSC)
APPLICATION DEADLINE: 1/4/13.
$ AVAILABLE: Please see URL for funding information.
ELIGIBILITY: Please see URL for eligibility information.
PURPOSE: The Texas Health and Human Services Commission (HHSC) announces the issuance of Request for Proposal (RFP) # 529-13-0004 for Actuarial Services for the Texas Medicaid Wellness Program. HHSC seeks to hire a knowledgeable, qualified, and responsive actuarial service provider who will assist HHSC to assess the efficiency and cost-effectiveness of the Texas Medicaid Wellness Program (WP) in accordance with the specifications contained in this Request for Proposals (RFP).
All communications relating to this RFP must be directed to the HHSC contact person named below. All other communications between a respondent and HHSC staff concerning this RFP are prohibited. In no instance is a respondent to discuss cost information contained in a proposal with the HHSC point of contact or any other staff prior to proposal evaluation. Failure to comply with this section may result in HHSC’s disqualification of the proposal.
CFDA: none
CONTACT: Steve R. Bailey, (512) 206-4653, e-mail: steve.bailey@hhsc.state.tx.us. For more information see http://www.hhsc.state.tx.us/contract/529130004/announcements.shtml
From Texas Health and Human Services Commission e-mail, 12/14/12
Subject(s) health care services
AHRQ Health Services Research Demonstration and Dissemination Grants (R18): PA-13-046
SOURCE: Agency for Healthcare Research and Quality (AHRQ)
APPLICATION DEADLINE: 1/25, 5/25, 9/25. Expires 9/26/15.
$ AVAILABLE: The number of awards is contingent upon AHRQ appropriations and the submission of a sufficient number of meritorious applications.
Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.
ELIGIBILITY: Public or nonprofit private institution, such as a university, college, or a faith-based or community-based organization; units of local or state government; eligible agency of the federal government; Indian/Native American tribal government (federally recognized); Indian/Native American tribal government (other than federally recognized); and Indian/Native American tribally designated organization.
PURPOSE: The Research Demonstration and Dissemination Grant (R18) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R18 research plan proposed by the applicant institution/organization must be related to the mission and portfolio priority research interests of AHRQ.
CFDA: 93.226
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/pa-files/PA-13-046.html
From AHRQ e-mail, 12/19/12
Subject(s) medical research
AHRQ Health Services Research Projects (R01): PA-13-045
SOURCE: Agency for Healthcare Research and Quality (AHRQ)
APPLICATION DEADLINE: 2/5, 6/5, 10/5. Expires 11/6/15.
$ AVAILABLE: The number of awards is contingent upon AHRQ appropriations and the submission of a sufficient number of meritorious applications.
Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.
ELIGIBILITY: Public or nonprofit private institution, such as a university, college, or a faith-based or community-based organization; units of local or state government; eligible agency of the federal government; Indian/Native American tribal government (federally recognized); Indian/Native American tribal government (other than federally recognized); and Indian/Native American tribally designated organization.
PURPOSE: The Research Project Grant (R01) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R01 research plan proposed by the applicant institution/organization must be related to the mission and portfolio priority research interests of AHRQ.
CFDA: 93.226
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/pa-files/PA-13-045.html
From AHRQ e-mail, 12/19/12
Subject(s) medical research
AIDS and Cancer Specimen Resource (ACSR) (UM1): RFA-CA-13-005
SOURCE: National Cancer Institute
APPLICATION DEADLINE: Letter of Intent: 1/14/13. Application: 2/14/13.
$ AVAILABLE: $3.9 million for one award.
ELIGIBILITY: Please see URL for eligibility information.
PURPOSE: In this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) is seeking applications for the AIDS and Cancer Specimen Resource (ACSR). The primary objective of the ACSR will be to acquire, store and equitably distribute tumor tissues, biological fluids and associated demographic data from patients with HIV-associated malignancies. In addition, the ACSR will serve and support biorepository banking activities for the AIDS Malignancy Clinical Trials Consortium (AMC). The AMC is an NCI funded, multicenter clinical trials group that performs clinical trials research in the treatment and prevention of HIV-associated malignancies. Due to the changing HIV epidemic and recent estimates of the associated malignancy trends, applicants are encouraged to focus their efforts in acquiring high priority collections that would include: 1) biospecimens with associated clinical, pathological, diagnostic, and demographic data; 2) fresh frozen biospecimens that are suitable for comprehensive molecular and genomic analyses; 3) biospecimens collected with informed consent acceptable for high level future use for deep sequencing and genome wide association studies; 4) biospecimens representing non-AIDS defining cancers (NADCs); and 5) biospecimens from the developing world, especially Sub-Saharan Africa.
CFDA: 93.393, 93.394, 93.395, 93.396, 93.399
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-005.html
From NIH Web site, accessed 12/19/12
Subject(s) medical research, HIV/AIDS research, technology
Health Information Exchange Infrastructure Development Initiative: 529-13-0009
SOURCE: Texas Health and Human Services Commission (HHSC)
APPLICATION DEADLINE: 1/8/13.
$ AVAILABLE: Please see URL for funding information.
ELIGIBILITY: Applications will be considered from:
1. Organizations that are receiving implementation funds under the Local Health Information Exchange Grant Program.
2. Other organizations that are providing health information exchange services to practitioners and providers in Texas communities.
PURPOSE: HHSC announces the release of Request for Proposal # 529-13-0009 for the Health Information Exchange Infrastructure Development Initiative. HHSC seeks Health Information Exchange Infrastructure Development Initiative services in accordance with the specifications contained in this Request for Proposals (“RFP”). Please check this link regularly for further information and updates: http://www.hhsc.state.tx.us/contract/529130009/docs/529130009.pdf.
CFDA: none
CONTACT: Richard Blincoe, (512) 206-5468, e-mail: richard.blincoe@hhsc.state.tx.us. For more information see http://www.hhsc.state.tx.us/contract/529130009/docs/529130009.pdf
From Electronic State Business Daily Web site, accessed 12/20/12
Subject(s) technology
Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19): PA-13-042
SOURCE: National Institute of Allergy and Infectious Diseases
APPLICATION DEADLINE: Letter of Intent: 2/15/13, 2/14/14, 2/13/15. Application: 3/15/13, 3/14/13, 3/13/15. Expires 3/14/15.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. NIAID anticipates that approximately $4 million total costs will be available in FY2014 to fund one to three new or renewal awards.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The goal of the IPCAVD Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) is to facilitate the translation of sufficiently advanced, innovative and promising vaccine candidates into early clinical testing. The IPCAVD program is designed to enable a multi-disciplinary team of investigators to complete all steps necessary from down-selection of a vaccine candidate through CGMP manufacture/testing/product release and into clinical trials. A preclinical research application alone is not sufficient for this announcement. Awards will provide the critical resources to allow the advancement of vaccine concepts to clinical trials within the first 5 years of the award. The reduced support for two additional years will support ongoing stability studies, updating regulatory submissions and further optimization as informed from the clinical studies. However, this funding opportunity will not provide funds for conducting the clinical studies; applicants are encouraged to collaborate with NIAID-supported clinical trial networks or to develop other relationships to support the clinical studies.
CFDA: 93.855, 93.856
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/pa-files/PA-13-042.html
From NIH Web site, accessed 12/19/12
Subject(s) medical research, HIV/AIDS research
STAR+PLUS, Medicaid Rural Service Area: RFP # 529-13-0042
SOURCE: Texas Health and Human Services Commission (HHSC)
APPLICATION DEADLINE: 5/1/13.
$ AVAILABLE: Please see URL for funding information.
ELIGIBILITY: Please see URL for eligibility information.
PURPOSE: HHSC announces the release of Request for Proposal # 529-13-0042 for STAR+PLUS, Medicaid Rural Service Area services. HHSC seeks STAR+PLUS, Medicaid Rural Service Area services in accordance with the specifications contained in this Request for Proposals.
All communications relating to this RFP must be directed to the HHSC contact person named below. All other communications between a respondent and HHSC staff concerning this RFP are prohibited. In no instance is a respondent to discuss cost information contained in a proposal with the HHSC point of contact or any other staff prior to proposal evaluation. Failure to comply with this section may result in HHSC's disqualification of the proposal.
CFDA: none
CONTACT: Rick Blincoe, (512) 206-5468, e-mail: richard.blincoe@hhsc.state.tx.us. For more information see http://www.hhsc.state.tx.us/contract/529130042/rfp.shtml
From Texas Health and Human Services Commission e-mail, 12/14/12
Subject(s) health care services, rural health services
Private Funding Opportunities
Finish Line Foundation Grants
SOURCE: Finish Line Foundation
APPLICATION DEADLINE: Ongoing.
$ AVAILABLE: Please see URL for funding information.
ELIGIBILITY: Please see URL for eligibility information.
PURPOSE: The Finish Line Foundation is offering grants to community-based athletic programs that address active lifestyle and team-building issues. Organizations committed to helping kids lead healthy, active lives or supporting kids with disabilities and disadvantages are eligible to apply for one of the Finish Line grants.
CONTACT: Please see URL for contact information. For more information see http://www.finishline.com/store/youthfoundation/guidelines.jsp
From DSHS School Health Program Friday Beat e-mail, 12/7/12
Subject(s) children's health, health promotion/wellness, disabilities
Innovative Research in Multiple Sclerosis
SOURCE: National Multiple Sclerosis Society
APPLICATION DEADLINE: 1/31/13.
$ AVAILABLE: $100,000 annual cash prize.
ELIGIBILITY: Any investigator(s) active in MS research is eligible for the prize. Nominee(s) may be from any institution or organization — public or private, government, as well as commercial entities. Nominees may also be at any stage of their professional career in MS research. There are no specific requirements for residency or citizenship. Nominees need not be current or past grantees of the National MS Society.
Nominations must be submitted on behalf an individual, or team of individuals, by one or more colleagues or mentors. Self-nominations are not permitted.
PURPOSE: The National Multiple Sclerosis Society is accepting nominations for a new annual cash prize recognizing scientists whose inventive work is propelling measurable progress in multiple sclerosis research.
The Barancik Prize for Innovation in MS Research was established to recognize an exceptional scientist or team whose work in MS research has demonstrated outstanding innovation and originality. The prize is made possible through the support of the Charles and Margery Barancik SO Foundation.
The first prize will be given in May 2013. A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees for their exceptional innovation and originality, impact, potential of the research to lead to pathways for treatment and cure for MS, and accomplishments in MS research that merit recognition and indicate future leadership in the field.
CONTACT: Please see URL for contact information. For more information see http://www.nationalmssociety.org/ms-clinical-care-network/researchers/get-funding/barancik-prize-for-innovation-in-ms-research/index.aspx
From The Foundation Center's Health Funding Watch e-mail, 12/19/12
Subject(s) medical research, health professions training
Events
27th Annual Conference on Prevention of Child Abuse
SPONSOR: Prevent Child Abuse Texas.
WHEN: March 4-5.
WHERE: Omni Hotel at the Colonnade, 9821 Colonnade Blvd., (San Antonio, TX).
DESCRIPTION: This conference is designed to offer quality training and information on topics and model programs of interest to leaders in child abuse prevention: social workers, counselors, educators, child care and youth workers, law enforcement personnel, medical and legal professionals, foster parents, child welfare board volunteers, elected officials, and other interested child advocates.
Participants may attend their choice of a variety of workshops on child abuse and neglect prevention and educational programs or may select workshops for specialized training credits and professional development. For more information and to register, go to http://www.preventchildabusetexas.org/nextconference.html.
COST: $200.
CONTACT: For more information please see the web site at http://www.PreventChildAbuseTexas.org or e-mail Conferences@preventchildabusetexas.org.
From DSHS School Health Program Friday Beat e-mail, 12/14/12
Return to Alert